RECRUITING

SHARE Program: SUSTAIN

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of PROJECT SUSTAIN is to optimize Healthy Choices to advance an adaptive and scalable intervention designed to improve self-management of alcohol and HIV in Young People with HIV (YPWH) while understanding the context for state-wide implementation and sustainment in a Hybrid Experimental Design (HED). SUSTAIN utilizes mHealth and telehealth intervention delivery of Healthy Choices (HC), combined with text messaging between sessions, to increase the likelihood of daily medication adherence (primary outcome), and increase the likelihood of achieving viral suppression and meeting criteria for no risky alcohol use at month 3 (secondary outcome).

Official Title

Sustaining Healthy Choices: Optimizing a State-wide Scalable Intervention to Improve Alcohol and HIV Self-management in Adolescents and Emerging Adults

Quick Facts

Study Start:2025-03-20
Study Completion:2026-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06934395

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 29 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Be 18 years and 0 months to 29 years and 11 months.
  2. * Currently reside in Florida
  3. * History of alcohol use
  4. * Are not pregnant nor trying to conceive within the study's timeline
  5. * Are able to read and understand English
  6. * Have internet access via smartphone, tablet or computer
  7. * Are willing to provide informed consent.
  1. * Adults unable to consent
  2. * Prisoners
  3. * Those using long-acting injectables as HIV medication regimen

Contacts and Locations

Study Contact

Karen MacDonell, PhD
CONTACT
850-644-2334
karen.macdonell@med.fsu.edu
Sara Green, MSW
CONTACT
8506442334
sara.green@med.fsu.edu

Study Locations (Sites)

Florida State University, Center for Translational Behavioral Science
Tallahassee, Florida, 32310
United States
University of South Florida
Tampa, Florida, 33620
United States
Northeastern University
Boston, Massachusetts, 02115
United States
University of Michigan
Ann Arbor, Michigan, 48106
United States

Collaborators and Investigators

Sponsor: Florida State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-20
Study Completion Date2026-07-31

Study Record Updates

Study Start Date2025-03-20
Study Completion Date2026-07-31

Terms related to this study

Additional Relevant MeSH Terms

  • Hiv